Search Results - E. V. Voropaev

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Analyzing the Problem of Mass Rejection of Vaccination against COVID-19. Possible Solutions

    Analyzing the Problem of Mass Rejection of Vaccination against COVID-19. Possible Solutions by K. S. Korsak, E. V. Voropaev, I. O. Stoma

    Published 2022-09-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    The COVID-19 crisis as a vector for changes in healthcare

    The COVID-19 crisis as a vector for changes in healthcare by K. S. Korsak, E. V. Voropaev, A. A. Kovalev, T. M. Sharshakova, I. O. Stoma

    Published 2024-01-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Study of Humoral Immunity against Coronavirus Infection COVID-19 in Vaccinated Individuals with Vaccines Available in the Republic of Belarus (Sputnik V (Gam-COVID-Vac), RF and Sinopharm (BBIBP-CorV), PRC)

    Study of Humoral Immunity against Coronavirus Infection COVID-19 in Vaccinated Individuals with Vaccines Available in the Republic of Belarus (Sputnik V (Gam-COVID-Vac), RF and Sin... by K. S. Korsak, I. O. Stoma, E. V. Voropaev, O. V. Osipkina, A. A. Kovalev

    Published 2023-03-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Urobiota and urinary tract infections in liver cirrhosis

    Urobiota and urinary tract infections in liver cirrhosis by E. G. Malaeva, I. O. Stoma, E. V. Voropaev, O. V. Osipkina, A. A. Kovalev

    Published 2025-02-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Efficacy of COVID-19 vaccination in organized group: results of a prospective study

    Efficacy of COVID-19 vaccination in organized group: results of a prospective study by I. O. Stoma, E. S. Korsak, E. V. Voropaev, O. V. Osipkina, A. A. Kovalev, O. L. Tumash, D. D. Redko

    Published 2023-01-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS­-CoV-­2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28)

    Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS­-CoV-­2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28) by I. O. Stoma, E. V. Voropaev, E. I. Mikhailova, D. M. Los, O. V. Osipkina, A. Yu. Braga, A. A. Kovalev, A. V. Molchanova, N. V. Trofimova, O. S. Pershenkova, B. S. Yaroshevich, M. N. Mirge

    Published 2024-07-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS

    RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS by S. V. Zhavoronok, V. R. Gutmane, T. M. Baryash, O. V. Soldatenko, T. V. Znovets, V. M. Mitsura, E. V. Voropaev, E. L. Gasich, E. N. Yagovdik-Telezhnaja, L. V. Sivachenko, L. A. Anisko, L. S. Zhmurovskaja, S. V. Krapivina, N. N. Yurovskij, I. V. Yurkevich, I. A. Karpov

    Published 2018-10-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Evaluation of Immunogenicity of Inactivated Whole-Virion Booster Vaccine against SARS-CoV-2 in a phase I, II Clinical Trial

    Evaluation of Immunogenicity of Inactivated Whole-Virion Booster Vaccine against SARS-CoV-2 in a phase I, II Clinical Trial by I. O. Stoma, E. V. Voropaev, E. I. Mikhailova, K. S. Korsak, O. V. Osipkina, A. V. Molchanova, A. A. Kovalev, D. M. Los, A. A. Ziatskov, A. S. Shaforost, M. N. Yatsuk, A. Yu. Braga, N. V. Trofimova, A. M. Dronina, E. L. Gasich, V. A. Gorbunov, A. Ev. Hancharou

    Published 2025-01-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: